J C Oosterwijk
Overview
Explore the profile of J C Oosterwijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van de Beek I, Smets E, Legdeur M, de Hullu J, Lok C, Buist M, et al.
J Community Genet
. 2019 Jun;
11(2):183-191.
PMID: 31168696
The new Dutch guidelines on hereditary and familial ovarian carcinoma recommend genetic testing of all patients with epithelial ovarian cancer (EOC). With this study, we aimed to obtain insight into...
2.
Heeg E, Schreuder K, Spronk P, Oosterwijk J, Marang-van de Mheen P, Siesling S, et al.
Eur J Surg Oncol
. 2019 Jan;
45(4):560-566.
PMID: 30621962
Purpose: Patients may transfer of hospital for clinical reasons but this may delay time to treatment. The purpose of this study is to provide insight in the extent of hospital...
3.
Moghadasi S, Grundeken V, Janssen L, Dijkstra N, Rodriguez-Girondo M, van Zelst-Stams W, et al.
Clin Genet
. 2017 Jun;
93(1):52-59.
PMID: 28589637
Brcapro: 1.02, 95% CI: [0.75-1.38] and 0.94, 95% CI: [0.68-1.31], respectively). Myriad underestimated the number of carriers in up to 69% of the cases. BRCAPRO showed a non-significant, higher AUC...
4.
van Driel C, Oosterwijk J, Meijers-Heijboer E, van Asperen C, Zeijlmans van Emmichoven I, de Vries J, et al.
Breast
. 2016 Sep;
30:66-72.
PMID: 27639031
Objectives: Women seeking counseling because of familial breast cancer occurrence face difficult decisions, such as whether and when to opt for risk-reducing mastectomy (RRM) in case of BRCA1/2 mutation. Only...
5.
Kaufmann J, Krapels I, Van Brussel B, Zekveld-Vroon R, Oosterwijk J, van Erp F, et al.
Public Health Genomics
. 2013 Nov;
17(1):16-22.
PMID: 24216604
Objective: Universal newborn screening for hemoglobinopathies started in The Netherlands in 2007. Herewith severe conditions, such as sickle cell disease, β-thalassemia major and hemoglobin H disease are putatively identified. Additionally,...
6.
de Bock G, Vermeulen K, Jansen L, Oosterwijk J, Siesling S, Dorrius M, et al.
Br J Cancer
. 2013 Apr;
108(8):1579-86.
PMID: 23579217
Background: There is no consensus on the most effective strategy (mammography or magnetic resonance imaging (MRI)) for screening women with BRCA1 or BRCA2 mutations. The effectiveness and cost-effectiveness of the...
7.
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott R, McGuffog L, et al.
Br J Cancer
. 2012 Jun;
106(12):2016-24.
PMID: 22669161
Background: The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB)...
8.
Voorwinden J, Jaspers J, ter Beest J, Kievit Y, Sijmons R, Oosterwijk J
Clin Genet
. 2011 Nov;
81(5):421-9.
PMID: 22091929
In predictive DNA testing for hereditary cancer, test results should traditionally be disclosed face-to-face. Increasingly, however, counselees ask to receive their test result at home by letter. To compare the...
9.
Schade van Westrum S, Hoogerwaard E, Dekker L, Standaar T, Bakker E, Ippel P, et al.
Neurology
. 2011 Jun;
77(1):62-6.
PMID: 21700587
Objectives: Cardiac involvement has been reported in carriers of dystrophin mutations giving rise to Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). The progress of these abnormalities during long-term...
10.
Vos J, Oosterwijk J, Gomez-Garcia E, Menko F, Jansen A, Stoel R, et al.
Clin Genet
. 2010 Dec;
79(3):207-18.
PMID: 21114486
Previous studies on the counsellees' perception of DNA test results did not clarify whether counsellees were asked about their recollections or interpretations, and focused only on patients' own risks and...